Wenguang Liang

Bayer (United States) — United States

Medicine · Health Sciences

16h-index944citations37works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(9), Enzyme Structure and Function(7), Protein Structure and Dynamics(5), Mitochondrial Function and Pathology(4), Pancreatic function and diabetes(3)

Publications37 total

Author response: Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity
2025Open Access
Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity
2025Open Access
Laboratory Investigation on Shear Modulus and Damping Properties of Port Soft Clay Improved by Dynamic Compaction
Applied Sciences·2025· 1 citedOpen Access
Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity
2025Open Access
Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity
2025Open Access
Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity
2024Open Access
Production and characterization of homologous protoporphyrinogen IX oxidase (PPO) proteins: Evidence that small N-terminal amino acid changes do not impact protein function
PLoS ONE·2024· 3 citedOpen Access
Application of Methionine Increases the Germination Rate of Maize Seeds by Triggering Multiple Phenylpropanoid Biosynthetic Genes at Transcript Levels
Plants·2023· 6 citedOpen Access
New Genes Identified as Modulating Salt Tolerance in Maize Seedlings Using the Combination of Transcriptome Analysis and BSA
Plants·2023· 13 citedOpen Access
With the Help of Green Financial Instrument Innovation Todrive the Green Economy to Promote the "Double Carbon" Goal
Frontiers in Sustainable Development·2022Open Access
Structural basis for the mechanisms of human presequence protease conformational switch and substrate recognition
Nature Communications·2022· 20 citedOpen Access
Degradation of Alzheimer’s Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme
Journal of Molecular Biology·2021· 42 citedOpen Access
Structural analysis of Mycobacterium tuberculosis M13 metalloprotease Zmp1 open states
Structure·2020· 15 citedOpen Access
Structural basis for the mechanisms of human presequence protease conformational switch and substrate recognition
Research Square (Research Square)·2020· 1 citedOpen Access
Degradation of Alzheimer’s amyloid-β by a catalytically inactive insulin-degrading enzyme
2020· 4 citedOpen Access
Pseudomonas aeruginosa exoenzyme Y directly bundles actin filaments
Journal of Biological Chemistry·2020· 16 citedOpen Access
Structural Analysis of <i>Mycobacterium Tuberculosis</i> M13 Metalloprotease Zmp1 Open State
SSRN Electronic Journal·2020Open Access
Reinvestigating the synthesis and efficacy of small benzimidazole derivatives as presequence protease enhancers
European Journal of Medicinal Chemistry·2019· 7 citedOpen Access
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening
European Journal of Medicinal Chemistry·2019· 21 citedOpen Access
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
eLife·2018· 147 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Wei‐Jen Tang(26), Jordan M Mancl(10), Hui Wei(9), Bridget Carragher(9), Clinton S. Potter(7), Rebecca Deprez‐Poulain(6), Benoît Déprez(6), Zhi‐Jie Liu(5), David E. Lee(4), Sheng Li(4), Damien Bosc(4), Julie Charton(4), Valérie Landry(4), Adrien Herlédan(4), Florence Leroux(4), Minglei Zhao(4), L.J. Bailey(3), Lauren A. McCord(3), Akiko Koide(3), Shohei Koide(3)